These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND IGL AND Prognosis
4 results:

  • 1. Minimal residual disease detection by next-generation sequencing of different immunoglobulin gene rearrangements in pediatric B-ALL.
    Chen H; Gu M; Liang J; Song H; Zhang J; Xu W; Zhao F; Shen D; Shen H; Liao C; Tang Y; Xu X
    Nat Commun; 2023 Nov; 14(1):7468. PubMed ID: 37978187
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. 5' Rapid amplification of cDNA ends (5'RACE): A simpler method to analyze immunoglobulin genes and discover the value of the light chain in chronic lymphocytic leukemia.
    Lan X; Ruminy P; Bohers E; Rainville V; Viennot M; Viailly PJ; Etancelin P; Tilly H; Mihailescu S; Bouclet F; Leprêtre S; Jardin F
    Leuk Res; 2022 Dec; 123():106952. PubMed ID: 36272389
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. BCL2 and MYC dual-hit lymphoma/leukemia.
    Tomita N
    J Clin Exp Hematop; 2011; 51(1):7-12. PubMed ID: 21628855
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.
    Tomita N; Tokunaka M; Nakamura N; Takeuchi K; Koike J; Motomura S; Miyamoto K; Kikuchi A; Hyo R; Yakushijin Y; Masaki Y; Fujii S; Hayashi T; Ishigatsubo Y; Miura I
    Haematologica; 2009 Jul; 94(7):935-43. PubMed ID: 19535347
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.